Evaluation of Positive and Negative Methods for Isolation of Circulating Tumor Cells by Lateral Magnetophoresis

Overview

Journal Micromachines (Basel)

Publisher MDPI

Date 2019 Jun 12

PMID 31181790

Citations 17

Authors

HaeLi Kang

Jinho Kim

Hyungseok Cho

Ki-Ho Han

Affiliations

Soon will be listed here.

Abstract

We developed an epithelial cell adhesion molecule (EpCAM)-based positive method and CD45/CD66b-based negative method for isolating circulating tumor cells (CTCs) by lateral magnetophoresis. The CTC recovery rate, white blood cell depletion rate, and purity of CTCs isolated using the positive and negative methods were analyzed using blood samples spiked with cancer cells with different expression levels of EpCAM. The aim was to assess the strengths and weaknesses of the positive and negative isolation methods for CTC-based diagnostics, prognostics, and therapeutics for cancer. The EpCAM-based positive method yielded CTCs of high purity, while the CD45/CD66b-based negative method yielded a large number of CTCs. In conclusion, the positive method shows promise for detecting somatic oncogenic mutations and the negative method shows promise for discovery of cellular and transcriptomic biomarkers of cancer.

Citing Articles

A Novel Size-Based Centrifugal Microfluidic Design to Enrich and Magnetically Isolate Circulating Tumor Cells from Blood Cells through Biocompatible Magnetite-Arginine Nanoparticles.

Farahinia A, Khani M, Morhart T, Wells G, Badea I, Wilson L Sensors (Basel). 2024; 24(18).

PMID: 39338775 PMC: 11436177. DOI: 10.3390/s24186031.

Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients.

Magnusson C, Augustsson P, Undvall Anand E, Lenshof A, Josefsson A, Welen K Anal Chem. 2024; 96(18):6914-6921.

PMID: 38655666 PMC: 11079855. DOI: 10.1021/acs.analchem.3c05371.

Liquid biopsy for gastric cancer: Techniques, applications, and future directions.

Diaz Del Arco C, Fernandez Acenero M, Ortega Medina L World J Gastroenterol. 2024; 30(12):1680-1705.

PMID: 38617733 PMC: 11008373. DOI: 10.3748/wjg.v30.i12.1680.

Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer.

Magnusson C, Augustsson P, Undvall Anand E, Lenshof A, Josefsson A, Welen K medRxiv. 2023; .

PMID: 38106097 PMC: 10723509. DOI: 10.1101/2023.12.04.23299128.

Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation.

Woo H, Kim S, Kang H, Lee S, Lee S, Kim J Theranostics. 2022; 12(8):3676-3689.

PMID: 35664056 PMC: 9131262. DOI: 10.7150/thno.72511.

References

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

Allard W, Matera J, Miller M, Repollet M, Connelly M, Rao C . Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10(20):6897-904. DOI: 10.1158/1078-0432.CCR-04-0378. View

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

Pantel K, Brakenhoff R, Brandt B . Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008; 8(5):329-40. DOI: 10.1038/nrc2375. View

de Bono J, Scher H, Montgomery R, Parker C, Miller M, Tissing H . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-9. DOI: 10.1158/1078-0432.CCR-08-0872. View

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S . Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009; 11(4):R46. PMC: 2750105. DOI: 10.1186/bcr2333. View

Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen E . Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 2010; 116(14):3330-7. DOI: 10.1002/cncr.25145. View

10.

Munz M, Murr A, Kvesic M, Rau D, Mangold S, Pflanz S . Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies. Cancer Cell Int. 2010; 10:44. PMC: 2989956. DOI: 10.1186/1475-2867-10-44. View

11.

Chen C, Chen K, Pan Y, Lee T, Hsiung L, Lin C . Separation and detection of rare cells in a microfluidic disk via negative selection. Lab Chip. 2010; 11(3):474-83. DOI: 10.1039/c0lc00332h. View

12.

Yu M, Stott S, Toner M, Maheswaran S, Haber D . Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011; 192(3):373-82. PMC: 3101098. DOI: 10.1083/jcb.201010021. View

13.

Liu Z, Fusi A, Klopocki E, Schmittel A, Tinhofer I, Nonnenmacher A . Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med. 2011; 9:70. PMC: 3119001. DOI: 10.1186/1479-5876-9-70. View

14.

Yu M, Bardia A, Wittner B, Stott S, Smas M, Ting D . Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013; 339(6119):580-4. PMC: 3760262. DOI: 10.1126/science.1228522. View

15.

Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H . Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 2013; 73(7):2059-69. DOI: 10.1158/0008-5472.CAN-12-0326. View

16.

Kim S, Han S, Park M, Jeon C, Joo Y, Choi I . Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads. Anal Chem. 2013; 85(5):2779-86. DOI: 10.1021/ac303284u. View

17.

Chin E, da Silva C, Hegde M . Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet. 2013; 14:6. PMC: 3599218. DOI: 10.1186/1471-2156-14-6. View

18.

Ozkumur E, Shah A, Ciciliano J, Emmink B, Miyamoto D, Brachtel E . Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013; 5(179):179ra47. PMC: 3760275. DOI: 10.1126/scitranslmed.3005616. View

19.

Tsongalis G, Peterson J, De Abreu F, Tunkey C, Gallagher T, Strausbaugh L . Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations. Clin Chem Lab Med. 2013; 52(5):707-14. DOI: 10.1515/cclm-2013-0883. View

20.

Gourikutty S, Chang C, Poenar D . An integrated on-chip platform for negative enrichment of tumour cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2016; 1028:153-164. DOI: 10.1016/j.jchromb.2016.06.016. View